GMI

AHCC appears to be a safe adjuvant antitumor agent in combination with traditional chemotherapeutic agents not metabolized via the CYP450 2D6 liver enzyme pathway.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *